Rizvi Syed Ali-aamir
Insider CIK 1897621 · RCKT Chief Medical Officer · CRBU Chief Medical Officer · PSTX Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RCKT ROCKET PHARMACEUTICALS, IN | A Award deriv | 2026-02-11 | 2026-02-13 | 93,037 | — | $0 | 93,037 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award | 2026-02-11 | 2026-02-13 | 61,963 | — | $0 | 407,874 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award deriv | 2025-10-06 | 2025-10-08 | 383,854 | — | $0 | 383,854 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award | 2025-10-06 | 2025-10-08 | 283,018 | — | $0 | 283,018 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award | 2025-10-06 | 2025-10-08 | 62,893 | — | $0 | 345,911 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | D To issuer deriv | 2025-01-08 | 2025-01-08 | 250,000 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | U Tender | 2025-01-08 | 2025-01-08 | 185,000 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award deriv | 2024-04-01 | 2024-04-03 | 250,000 | — | $0 | 250,000 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award | 2024-04-01 | 2024-04-03 | 185,000 | — | $0 | 185,000 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | A Award deriv | 2023-02-21 | 2023-02-23 | 131,000 | — | $0 | 131,000 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | S Sale | 2023-01-19 | 2023-01-20 | 5,627 | $6.31 | $35.5K | 59,373 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | A Award deriv | 2022-01-25 | 2022-01-25 | 161,250 | — | $0 | 161,250 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | A Award | 2022-01-25 | 2022-01-25 | 60,000 | — | $0 | 65,000 | SEC↗ |